Sinco Pharma (06833) announced interim results
- RevenueRMB10.3bn
- Net profitRMB19.9M
- Profit attributable to ownersRMB19.9M
- Revenue YoY-13.7%
- Net profit YoY-18.4%
- Depreciation & amortisationHK$25.6M
- Capital expenditureHK$-27.8M
- Interest-bearing debtHK$1.8bn
Source Sinco Pharma



